U.S. starts national Medicare coverage policy review for Biogen's Aduhelm
Go back to U.S. starts national Medicare coverage policy review for Biogen's Aduhelm| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 217.70 +1.05 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.65 | 52 Week High | $333.65 | |||
| Open | $218.11 | 52 Week Low | $223.02 | |||
| Day High | $219.30 | P/E | 27.87 | |||
| Day Low | $216.78 | EPS | $7.81 | |||
| Volume | 47,620 | |||||

